Cognita Labs

What Cognita Labs does

Cognita Labs is a U.S.-based medical device company founded in 2013 and headquartered in Santa Ana, California, focused on developing products for pulmonary diagnosis and management. According to Fact.MR market research, the company is positioned as a key participant in the digital respiratory devices market, operating alongside competitors such as COHERO Health, Adherium, Teva Pharmaceuticals, and Propeller Health. Its stated functional scope covers smart inhalers, IoT-connected respiratory devices, and remote patient monitoring solutions targeting asthma and COPD patients.

The company is privately held and operates with a small team of 1-10 employees. To date, it has raised approximately $1.13M in total disclosed funding, sourced exclusively from two National Science Foundation grants in 2014 ($225,000) and 2016 ($909,800), with no subsequent dilutive or non-dilutive capital events recorded. The company's official website is currently non-functional (loading/verification page), and no products, pricing models, customer references, management team, or regulatory clearances are publicly documented in the available sources.

Given the absence of disclosed commercial revenue, product specifications, FDA filings, or partnership agreements, the operating posture is best characterized as early-stage or pre-commercial R&D. The addressable market is large and growing rapidly — digital respiratory devices are projected to expand from USD 10.7B in 2024 to USD 121B by 2035 (26.1% CAGR) — but Cognita Labs' participation in that growth cannot be substantiated from current data.

Name

Cognita Labs

Website

https://cognitalabs.com

Company type

Private

Founded year

2013

Headcount range

1–10 employees

Short description

Cognita Labs is a Santa Ana, California-based medical device company founded in 2013 that develops products for pulmonary diagnosis and management, including digital and smart inhaler technologies targeting asthma and COPD patients.

Ownership category

akta.pro rank

Product category

Respiratory Medical Devices

NAICS

Medical and Diagnostic Laboratories (6215)

akta.pro primary industry

Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories) (HLAHAGAE)

akta.pro secondary industries

Blood Oxygen & Respiratory Monitoring (Pulse Oximetry, Capnography, Spirometry) (HLAHACAD), Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)

Keywords

• Digital respiratory devices
• Smart inhalers
• Pulmonary diagnostics
• Remote patient monitoring
• Respiratory health management

Headquarters

HQ city

Santa Ana

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Core offering

Cognita Labs is a medical device company that develops digital respiratory devices for pulmonary diagnosis and management. The company's portfolio centers on smart inhalers and IoT-connected devices designed to support patients with asthma and COPD, enabling connected monitoring and improved respiratory care outcomes.

Differentiator

Problem solved

Functional benefit

Products and services

• Digital Respiratory Devices
• Smart Inhalers
• IoT-connected Pulmonary Devices

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered minor.

• COHERO Health Inc.minorOthersCOHERO Health Inc. is listed alongside Cognita Labs as a key player in the digital respiratory devices market according to Fact.MR's market research report. This appears to be a market positioning listing rather than an explicit partnership.
• Adherium LimitedminorOthersAdherium Limited is listed alongside Cognita Labs as a key player in the digital respiratory devices market according to Fact.MR's market research report. This appears to be competitive market context rather than explicit partnership.
• Teva Pharmaceuticals Industries Ltd.minorOthersTeva Pharmaceuticals Industries Ltd. is listed alongside Cognita Labs as a key player in the digital respiratory devices market according to Fact.MR's market research report. This is competitive market context.
• Propeller HealthminorOthersPropeller Health is listed alongside Cognita Labs as a key player in the digital respiratory devices market according to Fact.MR's market research report. This is competitive market context.

Scale indicators1 record

Recent moves3 records

Expansion highlights2 records

Direct peers

• Propeller Health: Propeller Health is a leading smart inhaler and digital respiratory health company, acquired by ResMed for $225M. It directly competes with Cognita Labs in connected inhaler sensors and respiratory remote monitoring for asthma and COPD patients.
• Adherium: Adherium develops smart inhaler sensors and digital respiratory adherence solutions. It is explicitly named alongside Cognita Labs as a key player in the digital respiratory devices market and competes directly in connected inhaler technology.
• COHERO Health: COHERO Health offers digital respiratory health tools including smart spirometers and inhaler sensors. It is referenced alongside Cognita Labs as a key player in the digital respiratory devices market and serves overlapping asthma/COPD patient populations.

Broad incumbents

• Teva Pharmaceutical Industries: Teva is a global pharmaceutical company with a major respiratory franchise (including Digihaler digital inhalers). Named alongside Cognita Labs as a key player in digital respiratory devices, Teva operates at much greater scale across both drug and device categories.
• ResMed: ResMed is a global leader in sleep and respiratory care devices, and acquired Propeller Health. As the parent of Propeller, ResMed competes in the same smart inhaler / digital respiratory space as Cognita Labs from a position of dominant scale.
• Philips Respironics: Philips Respironics is a major manufacturer of respiratory care devices, ventilators, and CPAP/BiPAP systems. It overlaps with Cognita Labs in respiratory device manufacturing and increasingly in connected/remote monitoring capabilities.
• AstraZeneca: AstraZeneca is a leading respiratory pharmaceutical company (Symbicort, Fasenra) actively investing in digital respiratory health and connected inhaler programs. It competes for the same asthma/COPD patient relationships as Cognita Labs from a pharma-plus-digital perspective.
• GSK: GSK has a major respiratory portfolio (Trelegy, Nucala) and has invested in digital inhaler and connected respiratory health initiatives, competing for the same chronic respiratory patient management opportunity as Cognita Labs.
• Aptar Pharma: Aptar Pharma is a leading manufacturer of inhaler devices, valves, and drug delivery systems. It overlaps with Cognita Labs in inhalation device technology and serves many of the same pharmaceutical partners in respiratory drug-device combination products.

Others

• Sensirion: Sensirion manufactures high-precision environmental and medical sensors, including flow sensors used in respiratory devices. It is an enabling technology supplier rather than a direct competitor, but its components underpin smart inhaler and respiratory monitoring devices similar to Cognita Labs' products.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/cognita-labs

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cognita Labs